Discussion in 'Other reviews with a public consultation process' started by Hutan, Jul 1, 2021.
From the News from Germany thread:
Here is the document translated with google translate, if that helps anyone: https://translate.google.com/transl...enntnisstand_berichtsplan_v1-0.pdf?rev=209654
Thanks for the idea.
Here is the document translated with deepL which usually produces better results than google translate
Are there any limitations as to who can submit feedback?
Afaik there is no limitation. They are also active on twitter (reading and replying).
Here is the tweet:
Here is their press release:
And here again the DeepL translated version in english:
From the press release:
"Myalgic encephalomyelitis / chronic fatigue syndrome: IQWiG invites comments on the report planThe BMG has commissioned the Institute to present the current state of scientific knowledge on ME/CFS. Now the Institute is releasing its intended working method for comment.
On behalf of the Federal Ministry of Health (BMG), the Institute for Quality and Efficiency in Health Care (IQWiG) is compiling the current state of scientific knowledge on the disease myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS).
In the first phase of the two-year project, the Institute prepared the report plan, i.e. documented the methods it will use for the report. Comments on this document can be submitted until 11.08.2021."
Is there any way there could be an interim warning of there being evidence of harm for some participants in GET and CBT aimed at treating/curing the underlying ME/CFS?
We singularly failed to achieve this in relation the NICE guidelines for ME/CFS during their rewriting process here in the UK, but NICE did add a provisional warning against GET to their interim Covid guidelines.
obviously the most important part is what diagnostic criteria for ME/CFS has been used in the studies to be considered a study they include in their report. They only say "for example canadian consensus criteria or other data that makes it plausible that the patients had ME/CFS"
I think thats already too vague. Its not like we have 1000 good diagnostic criterias... plus the free ticket of just making it sound plausible that they had ME/CFS is worrying, too.
Is there any good study out there that is beneficial for ME/CFS that didnt use CCC or ICC? Because otherwise my first critique would be to already determine which criteria they will accept and be strict with it with no room to play around. Keep in mind they will only include studies post 2011 anyways.
To update the development:
The IQWiG wanted to include 3 Experts for ME/CFS for their review.
They changed that to two doctors who are familiar with ME/CFS and a psychiatrist or psychotherapist who is familiar with ME/CFS.
I contacted a known psychiatrist in germany who says that CBT/GET are trash. He replied that he already applied but they denied him because of conflict of interest. They refused to give a further explanation what kind of conflict of interest there is.
They also refuse to work together with patientorganisations.
So its pretty clear, they are supposed to praise CBT/GET and prepared everything to do so.
I have to edit the list of doctors they are looking for. They initially looked for 2 doctors who are experts for me/cfs and changed it to:
1 doctor who is an me/cfs expert (they state for example internist or virologist)
1 GP who just knows me/cfs
1 Psychiatrist/Psychotherapist who knows me/cfs
thanks @Joh for pointing this out
"Since the present research question is an evidence mapping, no statements on benefits and harms [of therapeutic programs] are made. However, if evidence of sufficient quality emerges, a selection of 2 therapeutic programs will be made to evaluate if they are useful (see following section)."
Not sure if I understood correctly but I can find this quote only on p. 10 (not 17) [p. 8 of the translated version] and it seems to only refer to the section 4.2. "Evidence mapping of therapy options relevant to health care provision". It's from that section's chapter 4.2.3 "Information procurement".
Details on how to assess benefits and harms are given in the following section 4.3 "Benefit Assessment" / esp. chapt. 4.3.3 "Information evaluation and synthesis".
I'm too brain-fogged ATM to understand this report plan's structure and much of its content. I too think it's weird how they anticipate the number of "therapeutic programs" for which there may be sufficient quality of evidence.
I will try to post some thoughts on the report later. I have not the expertise to understand most methodological details though.
Any thoughts, help, comments would be highly appreciated.
Apologies for the short notice – have been struggling with diverse issues lately and still do, but I hope I will be able to submit some points that might not be sufficiently covered by others’ submissions.
I realize the date for submissions collides with the date for comments on the NICE guidance’s final version.
Hope that the automatic translation isn’t too difficult to understand even for those of you who have the methodological expertise.
(Edited for clarity and to add PDF of the report plan -- thanks to @alexoffline for the deepl translation and sharing it on OneDrive.)
Further comments will also be possible on the preliminary report -- but before the publication of the preliminary report (draft) there will be a "user testing".
I haven't understood yet how people for the "user testing" will be elected.
(Edit: typos/ grammar)
I dont know if it's OK to name names, but aside from e.g. Dr Chirazi Stark, have you heard of Dr Leussink in Meerbusch (neurologist)?
How does this work - do ME doctors have to apply there or is the iqwig approaching them?
By application, but the period closed already on July 5th.
More info on the project website: https://www.iqwig.de/projekte/n21-01.html
It has to be in German language and anonymous comments aren't allowed.
Edit: Further details here: (google translate)
I'll attach the template (deepl translate) for futher details.
Link to the original template here.
"The German ME/CFS Society [Deutsche Gesellschaft für ME/CFS -- DG ME/CFS] have submitted a 25-page comment on the reporting plan of the @iqwig . The comments will be published by IQWiG."
I asked the DG ME/CFS this afternoon if I could have a look at their comment. Would make things much easier.
If it looks like the submission by the Deutsche Gesellschaft für ME/CFS is something we could get behind, would it be worth us submitting a short comment primarily endorsing what they say?
It might be good to ask for patient representatives to be involved in the making of this guideline. You could refer to NICE or the Dutch guideline as examples of this.
Patient representatives can point out flaws or potential problems more rapidly when the report is still being written, which is likely a more effective method than only allowing comments on a draft version.
There are several influential publications that recommend involving patients in the creation of medical guidelines such as the Appraisal of Guidelines for Research and Evaluation (AGREE) and The Guideline International Network (GIN) documents. The following citations might be useful:
 Brouwers M, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in healthcare. CMAJ. 2010;182:E839–42.
 Boivin A, Currie K, Fervers B, Gracia J, James M, Marshall C, Sakala C, et al. Patient and public involvement in clinical guidelines: international experiences and future perspectives. Qual Saf Health Care. 2010 Oct;19(5):e22.
 Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, eds. Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press; 2011.
 Armstrong MJ, Mullins CD, Gronseth GS, Gagliardi AR. Impact of patient involvement on clinical practice guideline development: a parallel group study. Implement Sci. 2018 Apr 16;13(1):55.
I hope they will either publish the comment on their website on the weekend or if they don't want to publish it until the IQWiG will publish it, will send me a copy in confidentiality.
To clarify: I made all my posts here just as a simple forum member and private person, assuming that for any official submission on behalf of S4ME it is not enough time now. So just welcome any help and if I submit anything, would also mention that I put the feedback together with the help of individual forum members, and would be happy to name anyone who wanted to be named.
Or if someone wanted to submit an individual comment but needs someone to translate or edit, I would do my best to find a good translator or editor.
For any action on behalf of S4ME I think that would need to be agreed upon by the committee.
Actually, I think it would be great if S4ME wanted to be involved in the next steps, and would also be great if S4ME could reach out to the DG to exchange information. @Andy @Trish
Separate names with a comma.